Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neuropathic pain
Biotech
Vertex passes neuropathic pain test, teeing up pivotal trials
Vertex linked its NaV1.8 inhibitor to statistically significant improvements in pain intensity in people with painful diabetic peripheral neuropathy.
Nick Paul Taylor
Dec 13, 2023 7:52am
Gene therapy reduces chronic pain and chemo-induced neuropathy
Jul 31, 2023 9:30am
Sangamo lays off 27% of US staff in latest refocus
Apr 27, 2023 8:55am
Lexicon misses mark in phase 2 pain trial
Dec 22, 2022 10:26am
Non-opioid pain drug indirectly blocks a key ion channel
Nov 10, 2021 2:00pm
Potential pain remedy emerges from 'junkyard of cancer drugs'
Oct 27, 2021 9:52am